Lundbeck is committed to engaging in transparent and ethical funding practices with all of our partners. Lundbeck is a member of several scientific, multi-disciplinary partnerships with an array of stakeholders. Our focus is on contributing to future strategic directions as well as generating enablers that:
Today Lundbeck is recognized as an attractive partner within brain diseases and we use it as a stepping stone to create value. We continue our internal research and activities across the value chain and supplement with external collaborations. In fact, if we look at the success we have today and have had for the last 20 years, collaborations and partnerships have played an important role.
Lundbeck’s long experience and continuous work within diseases of the brain has provided us with a strong global network in preclinical and clinical neuroscience research. Our partners represent expertise from several scientific areas and are typically from academia, health organizations, regulatory authorities, patient groups, scientific and medical societies, and the pharmaceutical/biotech industry.
Partnerships provide Lundbeck with the opportunity to exchange expertise and insights that can support joint strategic projects. Depending on the scope, a partnership can provide access to, for example, research assays, biomarkers, validated clinical outcome measures (including digital tools), large databases, in addition to valuable networks.
The partnerships are typically created around a common goal where all partners contribute with human resources. Industry and society partners may also contribute with financial resources. Partnerships normally run for a period of 2-5 years.
Lundbeck remains committed to sustainability through our comprehensive strategy.
We pursue our business purpose guided by several pillars and our Code of Conduct.
Discover our projects and compounds in development.